Tvardi Therapeutics, Inc. (TVRD )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TVRD
- Company Tvardi Therapeutics, Inc.
- Price $1.5
- Changes Percentage -36.44
- Change -0.86
- Day Low $1.5
- Day High $2.48
- Year High $43.65
- Year Low $2.75
- Market Cap $27,674,965
- Price Avg 50 EMA (D) $3.39
- Price Avg 200 EMA (D) $9.95
- Exchange NASDAQ
- Volume 56,770
- Average Volume 50,106
- Open $2.39
- Previous Close $2.36
- EPS -0.27
- PE -10.93
- Earnings Announcement 2026-05-08 12:30:00
- Shares Outstanding $9,381,344
Company brief: TVARDI THERAPEUTICS, INC. (TVRD )
- Healthcare
- Biotechnology
- Mr. Imran Alibhai, Ph.D.
- https://tvarditherapeutics.com BioSpace +4
- US
- N/A
- 04-16-2025
- US1407553072
Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).